"Oncogene Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION).
| Descriptor ID |
D015513
|
| MeSH Number(s) |
D12.776.624.664
|
| Concept/Terms |
Oncogene Proteins- Oncogene Proteins
- Proteins, Oncogene
- Oncogene Products
- Products, Oncogene
- Oncoproteins
- Oncogene Product
- Product, Oncogene
- Oncogene Protein
- Protein, Oncogene
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins".
This graph shows the total number of publications written about "Oncogene Proteins" by people in this website by year, and whether "Oncogene Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 1 | 0 | 1 |
| 2007 | 2 | 2 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 3 | 5 |
| 2012 | 4 | 1 | 5 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 1 | 2 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oncogene Proteins" by people in Profiles.
-
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. Cell Rep. 2019 10 22; 29(4):889-903.e10.
-
CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism. Sci Adv. 2019 07; 5(7):eaax2887.
-
P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-ß1, -ß2, and -ß3 Translation. Am J Respir Cell Mol Biol. 2019 02; 60(2):221-231.
-
Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer. Cancer Lett. 2018 12 01; 438:86-96.
-
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors. PLoS One. 2018; 13(1):e0187878.
-
NUT midline carcinoma of the larynx: an international series and review of the literature. Histopathology. 2017 May; 70(6):861-868.
-
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study. Br J Cancer. 2015 Jun 30; 113(1):57-63.
-
Whole-genome characterization of chemoresistant ovarian cancer. Nature. 2015 May 28; 521(7553):489-94.
-
N-linked glycan profiling in neuroblastoma cell lines. J Proteome Res. 2015 May 01; 14(5):2074-81.
-
A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling. Cancer Cell. 2014 Dec 08; 26(6):797-812.